Trading Options with an Edge
Select Page

ICPT

Search by
TICKER SYMBOL

Intercept Pharmaceuticals Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

15.67

0.57

(3.775%)

Volume:

541,433

52 week range:

11.6 - 43.16

Market Cap:

520.263M

Company Description:

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.